04/25/2024 4:51 PM | CITADEL ADVISORS LLC (Filed by) Marinus Pharmaceuticals (Subject)
| Form SC 13G | |
04/19/2024 5:04 AM | Marinus Pharmaceuticals (Subject) TANG CAPITAL PARTNERS LP (Filed by)
| Form SC 13G | |
04/15/2024 6:32 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/04/2024 7:00 AM | Marinus Pharmaceuticals (Filer)
| Form DEF 14A | |
04/04/2024 7:02 AM | Marinus Pharmaceuticals (Filer)
| Form DEFA14A | |
03/27/2024 10:55 AM | Braunstein Scott (Reporting) Marinus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 11:18 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by) Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
|
02/14/2024 9:35 AM | Marinus Pharmaceuticals (Subject) PRUDENTIAL FINANCIAL INC (Filed by) PRUDENTIAL FINANCIAL INC (Filed by)
| Form SC 13G | |
02/14/2024 8:04 AM | Avoro Capital Advisors LLC (Filed by) Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/13/2024 11:13 AM | Marinus Pharmaceuticals (Subject) SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/08/2024 12:56 PM | JENNISON ASSOCIATES LLC (Filed by) Marinus Pharmaceuticals (Subject)
| Form SC 13G | |
02/07/2024 6:25 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/06/2024 10:58 AM | FRANKLIN RESOURCES INC (Filed by) Marinus Pharmaceuticals (Subject)
| Form SC 13G | |
01/19/2024 3:18 PM | Braunstein Scott (Reporting) Marinus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:19 PM | Marinus Pharmaceuticals (Issuer) Pfanstiel Steven (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:20 PM | Hulihan Joseph (Reporting) Marinus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:21 PM | MANNING MARTHA E (Reporting) Marinus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:21 PM | Marinus Pharmaceuticals (Issuer) Shafer Christina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:22 PM | Marinus Pharmaceuticals (Issuer) MAYLEBEN TIMOTHY M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:23 PM | Austin Charles (Reporting) Marinus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:23 PM | Marinus Pharmaceuticals (Issuer) Nochur Sara (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:25 PM | Fischer Seth H. Z. (Reporting) Marinus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:26 PM | Ezickson Elan (Reporting) Marinus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:27 PM | Marinus Pharmaceuticals (Issuer) Silverstein Christine Berni (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:27 PM | Johnson Marvin (Reporting) Marinus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:28 PM | Marinus Pharmaceuticals (Issuer) Noonberg Sarah B. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 6:04 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/28/2023 6:05 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2023 6:31 AM | Marinus Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023 6:11 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/28/2023 6:05 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/19/2023 7:02 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/21/2023 6:00 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/15/2023 6:00 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/10/2023 6:55 AM | Marinus Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023 6:10 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2023 8:05 PM | Hulihan Joseph (Reporting) Marinus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2023 8:05 PM | MANNING MARTHA E (Reporting) Marinus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2023 8:05 PM | Marinus Pharmaceuticals (Issuer) Pfanstiel Steven (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2023 8:05 PM | Braunstein Scott (Reporting) Marinus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2023 8:05 PM | Marinus Pharmaceuticals (Issuer) Shafer Christina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
His win rate puts Warren Buffett to shame… (Ad) Not long ago I joined Phil Ash for a private one-on-one interview.
And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015…
Without a single loss. Click here now for the full story. |
05/30/2023 7:45 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/17/2023 8:02 PM | Marinus Pharmaceuticals (Issuer) Noonberg Sarah B. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
05/17/2023 8:08 PM | Marinus Pharmaceuticals (Issuer) Noonberg Sarah B. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/11/2023 7:01 AM | Marinus Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/11/2023 6:03 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |